{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:14Z","timestamp":1791925334855,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jchf.2024.05.014","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:04:41Z","timestamp":1720623881000},"page":"1961-1978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Management of Iron Deficiency in Heart\u00a0Failure"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-8025","authenticated-orcid":false,"given":"Kazuhiko","family":"Kido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Beavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Dulnuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-5007","authenticated-orcid":false,"given":"Nadia","family":"Fida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Guglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyedika J.","family":"Ilonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9212-7070","authenticated-orcid":false,"given":"Nikhil","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-3628","authenticated-orcid":false,"given":"Navin","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-7289","authenticated-orcid":false,"given":"Bhavadharini","family":"Ramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa A.","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2024.05.014_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cardfail.2023.03.025","article-title":"Iron deficiency in heart failure: a scientific statement from the Heart\u00a0Failure Society of America","volume":"29","author":"Beavers","year":"2023","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib2","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ejhf.139","article-title":"High prevalence of iron deficiency in patients with acute decompensated heart failure","volume":"16","author":"Cohen-Solal","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib3","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/ehf2.13265","article-title":"Iron deficiency in heart failure","volume":"8","author":"Loncar","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.05.014_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.05.014_bib6","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2024.05.014_bib7","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2024.05.014_bib8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/ejhf.2270","article-title":"Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF","volume":"23","author":"McEwan","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2024.05.014_bib10","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.05.014_bib11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ejhf.2860","article-title":"Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.05.014_bib13","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of Ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jchf.2024.05.014_bib14","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.05.014_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"McDonagh","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"Suppl 2","key":"10.1016\/j.jchf.2024.05.014_bib16","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"Danielson","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2024.05.014_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ehf2.12400","article-title":"Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients","volume":"6","author":"Martin-Malo","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/07853890.2020.1867323","article-title":"Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice","volume":"53","author":"Richards","year":"2021","journal-title":"Ann Med"},{"key":"10.1016\/j.jchf.2024.05.014_bib19","first-page":"2976","article-title":"Practical guidance for diagnosing and treating iron deficiency in patients with heart failure: why, who and how?","volume":"11","author":"Sindone","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jchf.2024.05.014_bib20","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/ejhf.2338","article-title":"Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart\u00a0Failure Registry","volume":"23","author":"Becher","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/ajhp\/zxad149","article-title":"Evaluation of a pharmacist-provider collaborative clinic for treatment of iron deficiency in patients with heart failure","volume":"80","author":"Kido","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jchf.2024.05.014_bib22","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1345\/aph.1K187","article-title":"Risk of infection with intravenous iron therapy","volume":"41","author":"Maynor","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jchf.2024.05.014_bib24","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/AOG.0000000000004477","article-title":"Anemia in pregnancy: ACOG practice bulletin, number 233","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jchf.2024.05.014_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2020.12.021","article-title":"Iron deficiency for prognosis in acute coronary syndrome\u2013a systematic review and meta-analysis","volume":"328","author":"Reinhold","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2024.05.014_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115728","article-title":"Excess iron intake induced liver injury: The role of gut-liver axis and therapeutic potential","volume":"168","author":"Liu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jchf.2024.05.014_bib27","first-page":"128","article-title":"Guidelines on haemovigilance of post-transfusional iron overload","volume":"11","author":"Remacha","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jchf.2024.05.014_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2013.10.008","article-title":"Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis-A critical review","volume":"89","author":"Beguin","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jchf.2024.05.014_bib29","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00402-1","article-title":"Ferric carboxymaltose iinfusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial","volume":"10","author":"Talboom","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jchf.2024.05.014_bib30","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ajh.26376","article-title":"Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: a randomized, placebo-controlled study (IRON-CLAD)","volume":"96","author":"Makharadze","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jchf.2024.05.014_bib31","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.1002\/ajh.24013","article-title":"Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation","volume":"90","author":"Jaspers","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jchf.2024.05.014_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.33935","article-title":"Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis","volume":"4","author":"Shah","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2024.05.014_bib33","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaip.2020.11.028","article-title":"Safety of intravenous iron following infusion reactions","volume":"9","author":"Stojanovic","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jchf.2024.05.014_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.4488","article-title":"Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions","volume":"5","author":"Arastu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2024.05.014_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jchf.2024.05.014_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jchf.2023.11.006","article-title":"Meta-analysis and metaregression of the treatment effect of intravenous iron in iron-deficient heart failure","volume":"12","author":"Martens","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"16","key":"10.1016\/j.jchf.2024.05.014_bib37","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/eurheartj\/ehae086","article-title":"Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial","volume":"45","author":"Cleland","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.05.014_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5301\/ijao.5000607","article-title":"Anemia after continuous-flow left ventricular assist device implantation: characteristics and implications","volume":"40","author":"Amione-Guerra","year":"2017","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jchf.2024.05.014_bib39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/MAT.0000000000001585","article-title":"Prevalence of iron deficiency and iron administration in left ventricular assist device and heart transplantation patients","volume":"68","author":"Veenis","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.jchf.2024.05.014_bib40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.healun.2023.04.013","article-title":"Presence and impact of anemia in patients supported with left ventricular assist devices","volume":"42","author":"Tie","year":"2023","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2024.05.014_bib41","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/MAT.0000000000000904","article-title":"Intravenous versus oral iron replacement in patients with a continuous-flow left ventricular assist device","volume":"65","author":"Bode","year":"2019","journal-title":"ASAIO J"},{"key":"10.1016\/j.jchf.2024.05.014_bib42","article-title":"Safety and effectiveness of intravenous iron therapy in patients supported by durable left ventricular assist devices","volume":"11","author":"Peters","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jchf.2024.05.014_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14346","article-title":"Prevalence of iron deficiency in heart transplant recipients","volume":"35","author":"Brautaset Englund","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jchf.2024.05.014_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12146","article-title":"Inflammatory triggers of acute rejection of organ allografts","volume":"258","author":"Mori","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jchf.2024.05.014_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14695","article-title":"Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo","volume":"36","author":"Brautaset Englund","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jchf.2024.05.014_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.healun.2021.01.1390","article-title":"Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): a randomized clinical trial","volume":"40","author":"Brautaset Englund","year":"2021","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2024.05.014_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.jchf.2024.05.014_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235057","article-title":"Effect of ferric carboxymaltose supplementation in patients with heart failure with preserved ejection fraction: role of attenuated oxidative stress and improved endothelial function","volume":"14","author":"Mollace","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jchf.2024.05.014_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"L\u00f3pez-Vilella","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"37","key":"10.1016\/j.jchf.2024.05.014_bib50","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1093\/eurheartj\/ehae479","article-title":"Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial","volume":"45","author":"von Haehling","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.05.014_bib51","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1183\/09031936.00100510","article-title":"Iron deficiency is common in idiopathic pulmonary arterial hypertension","volume":"37","author":"Ruiter","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jchf.2024.05.014_bib52","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.05.014_bib53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/682217","article-title":"Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency","volume":"5","author":"Ruiter","year":"2015","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jchf.2024.05.014_bib54","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1513\/AnnalsATS.202009-1131OC","article-title":"Supplementation with iron in pulmonary arterial hypertension. Two randomized crossover trials","volume":"18","author":"Howard","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jchf.2024.05.014_bib55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2024.05.014_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.jchf.2024.05.014_bib57","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/ehf2.14286","article-title":"Hypophosphataemia risk associated with ferric carboxymaltose in heart failure: a pooled analysis of clinical trials","volume":"10","author":"Rosano","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jcph.1754","article-title":"Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction","volume":"61","author":"Dashwood","year":"2021","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jchf.2024.05.014_bib59","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bjh.18979","article-title":"Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-a 3-year experience from a single institution in Singapore","volume":"202","author":"Chu","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jchf.2024.05.014_bib60","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","article-title":"Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF","volume":"146","author":"Docherty","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.05.014_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jchf.2022.10.004","article-title":"Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart\u00a0Failure","volume":"11","author":"Packer","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib62","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/ejhf.2992","article-title":"Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors","volume":"25","author":"Marques","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib63","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cardfail.2022.12.007","article-title":"Combining iron supplements with SGLT2 inhibitor-stimulated erythropoiesis in heart failure: should we be worried about thromboembolic events?","volume":"29","author":"Packer","year":"2023","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib64","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/ejhf.3064","article-title":"Sodium-glucose cotransporter 2 inhibitors on top of intravenous iron in patients with heart failure and iron deficiency: any incremental effect?","volume":"25","author":"Savarese","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.05.014_bib65","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3324\/haematol.2014.111492","article-title":"Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management","volume":"99","author":"Rampton","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jchf.2024.05.014_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3352\/jeehp.2020.17.21","article-title":"Guidelines for the management of extravasation","volume":"17","author":"Kim","year":"2020","journal-title":"J\u00a0Educ Eval Health Prof"},{"key":"10.1016\/j.jchf.2024.05.014_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.05.014_bib68","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/phar.1525","article-title":"Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency","volume":"35","author":"Reed","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jchf.2024.05.014_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1074248421989871","article-title":"Safety and effectiveness of an accelerated intravenous iron administration protocol in hospitalized patients with heart failure","volume":"26","author":"Eche","year":"2021","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"}],"updated-by":[{"DOI":"10.1016\/j.jchf.2024.09.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000}}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924004335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924004335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:11:06Z","timestamp":1764551466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924004335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2213177924004335"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.05.014","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Iron Deficiency in Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}